vimarsana.com

Latest Breaking News On - லிச்ஃபீல்ட் கதீட்ரல் - Page 3 : vimarsana.com

COVID and mental health: ′I really struggled psychologically′ | Science| In-depth reporting on science and technology | DW

Depression takes toll on Nigerians amid COVID-19 One in three COVID-patients have neurological or psychiatric conditions The Lancet Psychiatry, found that Caroline is not alone. Far from it, actually: Researchers went through electronic health records of more than 236,000 COVID-19 patients mostly from the US and found that one in three, or 34 percent, had been diagnosed with a psychiatric or neurological condition within six months of being infected with coronavirus. Neurological conditions like stroke and dementia were rare, but 17 percent of COVID-patients were diagnosed with anxiety disorders and 14 percent with mood disorders like depression. The Oxford researchers also looked at two control groups of patients with influenza and patients with any respiratory tract infection (except for COVID) to make sure their numbers didn t just reflect the experience of the general public living through a pandemic.

Covid-19 news: EU drugs regulator reviewing Johnson & Johnson vaccine

Stephen Zenner/SOPA Images/Shutterstock Latest coronavirus news as of 5pm on 9 April The EU’s medicines regulator is reviewing a small number of reports of rare blood clots in people who received the Johnson & Johnson vaccine The European Union’s medicines regulator is reviewing four reported cases of rare blood clots associated with low levels of platelets – small particles in the blood that normally help in clotting – including one case which was fatal, in people who received the Johnson & Johnson covid-19 vaccine. The European Medicines Agency (EMA) is also reviewing five reported cases of a bleeding condition, called capillary leak syndrome, in people who received the Oxford/AstraZeneca covid-19 vaccine. “At this stage, it is not yet clear whether there is a causal association” between the vaccines and the reported conditions, the EMA said. Both the Oxford/AstraZeneca and Johnson & Johnson vaccines are based on viral vector technologies, which use inactivated cold

Covid-19 news: Italy, Spain, Belgium limit use of AstraZeneca vaccine

Covid-19 news: Italy, Spain, Belgium limit use of AstraZeneca vaccine
newscientist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newscientist.com Daily Mail and Mail on Sunday newspapers.

Covid-19 news: UK to offer under-30s alternative to AstraZeneca jab

Marco Cantile/LightRocket via Getty Images Latest coronavirus news as of 5pm on 7 April UK committee advises under-30s be offered alternative to AstraZeneca jab, while EU review finds no evidence age or gender are risk factors for side effects The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that people under the age of 30 with no underlying health conditions should be offered an alternative covid-19 vaccine instead of the Oxford/AstraZeneca shot where possible, due to evidence linking the vaccine to rare blood clots. A review by the UK’s medicines regulator found that by the end of March, 79 people in the UK had experienced rare blood clots following vaccination with the Oxford/AstraZeneca vaccine – 19 of whom had died. The UK Medicines and Healthcare products Regulatory Agency (MHRA) said this was not definitive evidence that the vaccine caused the clots but said the link was becoming firmer. However, both the MHRA in the UK and the EU’s medici

Covid vaccine rollout is still on target, ministers pledge

Covid vaccine rollout is still on target, ministers pledge
dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.